Gene Therapy Program | University of Pennsylvania
Biotechnology Research • 
Philadelphia, Pennsylvania, United States • 21-50 Employees
Company overview
| Headquarters | 125 S 31st St, Philadelphia, Pennsylvania, US |
| Website | |
| NAICS | 541714 |
| Keywords | Gene Therapy, Biomedical Research, Higher Education, Clinical Research, Rare Diseases, GLP, AAV, Translational Research, Genome Editing, Genetic Medicine, Vector Design, Orphan Disease, Discovery Research, Patient Registry, Lipid Nanoparticles, Genetic Therapies, Capsid Engineering, Adeno-Associated Viruses, Good Laboratory Practice/Glp, Good Manufacturing Practice/Gmp |
| Founded | 1993 |
| Employees | 21-50 |
Key Contacts at Gene Therapy Program | University of Pennsylvania
Fe Wright
Associate Director, Training And Documentation
Sissy Chikazawa
Associate Director, Large Animal Rescourcing
Zhe Zhang
Director, Biostatistics And Bioinformatics Core
Trevor Tierney
Associate Director
Rosemary Meggersee
Research Director
Hao Xu
Associate Director
Gene Therapy Program | University of Pennsylvania Email Formats
Gene Therapy Program | University of Pennsylvania uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@uphs.upenn.edu), used 33.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@uphs.upenn.edu | 33.3% |
{first name} | john@uphs.upenn.edu | 22.2% |
{first initial}{last name} | jdoe@upenn.edu | 11.1% |
{first initial} | j@upenn.edu | 11.1% |
{first name}{last name} | johndoe@upenn.edu | 11.1% |
About Gene Therapy Program | University of Pennsylvania
Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy. After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents. Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases. The Gene Therapy Program currently employs more than 350+ full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.
Gene Therapy Program | University of Pennsylvania revenue & valuation
| Annual revenue | $2,908,870 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Gene Therapy Program | University of Pennsylvania has 12 employees across 5 departments.
Departments
Number of employees
Funding Data
Gene Therapy Program | University of Pennsylvania has never raised funding before.
Croatia
Italy
Frequently asked questions
4.8
40,000 users
